Several reports on DPP3 have suggested its aberrant activity in cancers of multiple origins, such as breast cancer [20,26,42], lung cancer [24], ovarian cancer [22], endometrial cancer [22], colon cancer [30], and EC [32]. The gene discussed is DPP3; the disease is lung cancer.